Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Reprod Toxicol. 2015 Feb 16;52:57–61. doi: 10.1016/j.reprotox.2015.02.003

Table 1.

Estradiol accumulation by human luteinizing granulosa cells (hLGC) treated in vitro with 3.1 nM, 3.1 pM, or 3.1 fM TCDD at various time intervals. Values are given as a percentage relative to accumulation by untreated control cells (control = 100%).

Time Points Control 3.1 nM TCDD 3.1 pM TCDD 3.1 fM TCDD
4 hour 100% 153.2% (16.0) 158.2% (11.2) 137.5% (23.9)
8 hour 100% a 50.1% (16.6) b 51.6% (14.5) b 43.8% (12.3) b
12 hour 100% a 41.2% (10.6) b 26.7% (9.2) b 37.3% (7.8) b
24 hour 100% a 46.9% (15.6) b 44.7% (15.8) b 44.9% (18.8) b
36 hour 100% a 104.0% (9.3) 83.5% (8.2) 112.8% (11.7)
48 hour 100% a 88.2% (16.3) 93.0% (14.4) 84.6% (13.9)
a,b

Letter superscripts denote significance at each time period (within a given row), based on Tukey’s post-hoc test after one-way ANOVA (P < 0.05). Values within columns sharing the same superscripts do not differ significantly from one another. Parentheses denote ± (S.E.M.) reported as a percentage. N = 8 for each treatment group.